Style | Citing Format |
---|---|
MLA | Klashami ZN, et al.. "Investigating the Relationship Between the Vntr Variant of the Interleukin-1 Receptor Antagonist Gene and Coronary In-Stent Restenosis." Molecular Biology Reports, vol. 50, no. 10, 2023, pp. 8575-8587. |
APA | Klashami ZN, Mostafavi A, Roudbordeh MG, Abbasi A, Ebrahimi P, Asadi M, Amoli MM (2023). Investigating the Relationship Between the Vntr Variant of the Interleukin-1 Receptor Antagonist Gene and Coronary In-Stent Restenosis. Molecular Biology Reports, 50(10), 8575-8587. |
Chicago | Klashami ZN, Mostafavi A, Roudbordeh MG, Abbasi A, Ebrahimi P, Asadi M, Amoli MM. "Investigating the Relationship Between the Vntr Variant of the Interleukin-1 Receptor Antagonist Gene and Coronary In-Stent Restenosis." Molecular Biology Reports 50, no. 10 (2023): 8575-8587. |
Harvard | Klashami ZN et al. (2023) 'Investigating the Relationship Between the Vntr Variant of the Interleukin-1 Receptor Antagonist Gene and Coronary In-Stent Restenosis', Molecular Biology Reports, 50(10), pp. 8575-8587. |
Vancouver | Klashami ZN, Mostafavi A, Roudbordeh MG, Abbasi A, Ebrahimi P, Asadi M, et al.. Investigating the Relationship Between the Vntr Variant of the Interleukin-1 Receptor Antagonist Gene and Coronary In-Stent Restenosis. Molecular Biology Reports. 2023;50(10):8575-8587. |
BibTex | @article{ author = {Klashami ZN and Mostafavi A and Roudbordeh MG and Abbasi A and Ebrahimi P and Asadi M and Amoli MM}, title = {Investigating the Relationship Between the Vntr Variant of the Interleukin-1 Receptor Antagonist Gene and Coronary In-Stent Restenosis}, journal = {Molecular Biology Reports}, volume = {50}, number = {10}, pages = {8575-8587}, year = {2023} } |
RIS | TY - JOUR AU - Klashami ZN AU - Mostafavi A AU - Roudbordeh MG AU - Abbasi A AU - Ebrahimi P AU - Asadi M AU - Amoli MM TI - Investigating the Relationship Between the Vntr Variant of the Interleukin-1 Receptor Antagonist Gene and Coronary In-Stent Restenosis JO - Molecular Biology Reports VL - 50 IS - 10 SP - 8575 EP - 8587 PY - 2023 ER - |